Evidence of alternative or concomitant use of perforin- and Fas- dependent pathways in a T cell-mediated negative regulation of Ig production

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4391-4398

  Majlessi, Laleh ^a   Bordenave, Guy ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PERFORIN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL TRANSFER; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DOWN REGULATION; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033561671     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Shinkai, Y., K. Takio, and K. Okumura. 1988. Homology of perforin to the ninth component of complement (C9). Nature 334:525.
2. Kägi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
3. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponsting, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
4. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24:923.
5. b and of tolerance acquisition to this allotype. Res. Immunol. 146:213.
6. 1 hybrid mice. Eur. J. Immunol. 17:167.
7. a mouse strain of the "natural" suppressive activity of normal T splenocytes against the expression of Igh-1b allotype. I. Molecular aspects of the chronic suppression obtained. Eur. J. Immunol. 18:51.
8. a mice. J. Immunol. 151:1263.
9. b suppression. J. Immunol. 149:1881.
10. h/b homozygous mice and its abrogation by in vivo treatment with anti-CD8 monoclonal antibody. J. Exp. Med 168:891.
11. b suppression is restricted by major histocompatibility complex class I, but not class II molecules. Eur. J. Immunol. 27:1346.
12. Kägi, D., B. Odermatt, P. Seiler, R. M. Zinkernagel, M. Tak, and H. Hengartner. 1997. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186:989.
13. + type 2 cytotoxic T cells restricts their potential B cell helper activity. Eur. J. Immunol. 27:914.
14. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
15. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90:10340.
16. Watanabe, D., T. Suda, and S. Nagata. 1995. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 7:1949.
17. Wang, J., I. Taniuchi, Y. Maekawa, M. Howard, M. D. Cooper, and T. Watanabe. 1996. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 26:92.
18. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
19. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S.-T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
20. Takayama, H., H. Kojima, and N. Shinohara. 1995. Cytotoxic T lymphocytes: the newly identified Fas (CD95)-mediated killing mechanism and a novel aspect of their biological functions. Adv. Immunol. 60:289.
21. + T cells by a self-derived peptide. Nature 378:295.
22. Brossart, P., and M. J. Bevan. 1996. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J. Exp. Med. 183:2449.
23. Ozdemirli, M., M. El-Khatib, L. C. Foote, J. K. M. Wang, A. Marshak-Rothstein, T. L. Rothstein, and S.-T. Ju. 1996. Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferation responses. Eur. J. Immunol. 26:415.
24. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, H. Fukuyama, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93:2131.
25. Adachi, M., F. R. Watanabe, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
26. Kobayashi, S., T. Hirano, M. Kakinuma, and T. Uede. 1993. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem. Biophys. Res. Commun. 191:617.
27. Wu, J., T. Zhou, J. He, and J. D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461.
28. Chu, J. L., J. Drappa, A. Pamassa, and K. B. Elkon. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178:723.
29. Mariani, S., B. Matiba, E. A. Armandola, and P. H. Krammer. 1994. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24:3119.
30. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
31. Izui, S., V. E. Kelley, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
32. Shinkai, Y., G. Rathbun, K. P. Lam. E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855.
33. Parsons, M., L. A. Herzenberg, M. Stall, and L. A. Herzenberg. 1986. Mouse immunoglobulin allotypes. In Handbook of Experimental Immunlogy, 4th Ed. D. M. Weir and L. A. Herzenberg, eds. Blackwell Scientific Publ., Oxford, p. 97.1.
34. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.
35. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:2736.
36. Pearson, T., G. Galfre, A Ziegler, and C. Milstein. 1977. A myeloma hybrid producing antibody specific for an allotypic terminant on "IgD-like" molecules of the mouse. Eur. J. Immunol. 7:684.
37. Huang, C. M., M. Parsons, V. T. Oi, H. J. S. Huang, and L. A. Herzenberg. 1983. Genetic characterization of mouse immunoglobulin allotypic determinants (allotopes) defined by monoclonal antibodies, Immunogenetics 18:311.
38. + thymic precursor. J. Immunol. 151:1086.
39. Giese, T., and W. F. Davidson. 1994. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J. Immunol. 152:2000.
40. Maldonado, M. A., R. A. Eisenberg, E. Roper, P. L. Cohen, and B. L. Kotzin. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181:641.
41. b mRNA levels. J. Immunol. 150:858.
42. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441.
43. b mice are required to induce suppression of Igh-1b allotype expression. J. Immunol. 142:1.
44. a/b mice. J. Immunol. 151:1859.
45. Theofilopoulos, A. N., R. S. Balderas, Y. Gozes, M. T. Aguado, L. M. Hang, P. R. Morrow, and F. J. Dixon. 1985. Association of lpr gene with graft-vs-host disease-like syndrome. J. Exp. Med. 162:1.
46. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
47. Chu, J. L., P. Ramos, A. Rosendorff, Z. J. Nikolic, E. Lacy, A. Matsuzawa, and K. B. Elkon. 1995. Massive up-regulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393.
48. + T cells, respectively, mediate Fas-dependent and perform cytotoxic pathways. Eur. J. Immunol. 27:415.
49. Lagresle, C., C. Bella, P. T. Daniel, P. H. Krammer, and T. Defrance. 1995. Regulation of germinal center B cell differentiation: role of the human APO-1/Fas (CD95) molecule. J. Immunol. 154:5746.
50. Lagresle, C., P. Mondière, C. Bella, P. H. Krammer, and T. Defrance. 1996. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J. Exp. Med. 183: 1377.
51. 2a genes originate from two distinct isotypes. EMBO J. 8:3245.
52. 2a genes. Nature 298:82.
53. Jouvin-Marche, E., M. G. Morgado, C. Leguern, D. Voegtle, F. Bonhomme, and P.-A. Cazenave. 1989. The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 29:92.
54. b allotype. J. Immunol. 152:3342.